ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 253272 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 253272; 2) Community: the network communities that were significantly associated with the response to NSC 253272; 3) Molecule: the relationships between components within communities and NSC 253272; 4) MDR: the compounds that were significantly associated with the NSC 253272.

NSC Compound Enrichment Correlation
NSC 79304 Null 0.000193456494459354 0.53009091
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.000193456494459355 0.63575836
NSC 695636 1-Nonyl-3-(2',6'-dimethyl-3',5'-diethoxycarbonyl-1',4'-dihydropyridyl-4')pyridinium bromide 0.000260754310156449 0.45961295
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.000281397700245212 0.83115463
NSC 626162 Discorhabdin C . TFA 0.000281397700245212 0.82649043
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.000281397700245212 0.74440715
NSC 655305 Null 0.000281397700245212 0.84476788
NSC 664271 Null 0.000281397700245212 0.80791054
NSC 722565 Null 0.000305106126354731 0.68136174
NSC 372146 1,3,5-Triazine, 2-(1-methylethenyl)-2,4-diphenoxy- 0.000416348839396255 0.63046853
Total:103  Current:2    [First] [Prev] [Next] [Last]